(Q46407233)

21 December 2017

title

Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension (English)

1 reference

21 December 2017

author name string

T Dimitroulas

1

1 reference

21 December 2017

G Giannakoulas

2

1 reference

21 December 2017

T Sfetsios

3

1 reference

21 December 2017

H Karvounis

4

1 reference

21 December 2017

H Dimitroula

5

1 reference

21 December 2017

G Koliakos

6

1 reference

21 December 2017

L Settas

7

1 reference

21 December 2017

publication date

27 August 2008

1 reference

21 December 2017

published in

Rheumatology

1 reference

21 December 2017

volume

47

1 reference

21 December 2017

page(s)

1682-1685

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN346

10.1093/RHEUMATOLOGY/KEN346

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18753191

1 reference

21 December 2017